Skip to main content
Top
Published in: Vascular Cell 1/2013

Open Access 01-12-2013 | Research

Notch4 is required for tumor onset and perfusion

Authors: Maria José Costa, Xiaoqing Wu, Henar Cuervo, Ruchika Srinivasan, Seth K Bechis, Ellen Cheang, Olivera Marjanovic, Thomas Gridley, Christin A Cvetic, Rong A Wang

Published in: Vascular Cell | Issue 1/2013

Login to get access

Abstract

Background

Notch4 is a member of the Notch family of receptors that is primarily expressed in the vascular endothelial cells. Genetic deletion of Notch4 does not result in an overt phenotype in mice, thus the function of Notch4 remains poorly understood.

Methods

We examined the requirement for Notch4 in the development of breast cancer vasculature. Orthotopic transplantation of mouse mammary tumor cells wild type for Notch4 into Notch4 deficient hosts enabled us to delineate the contribution of host Notch4 independent of its function in the tumor cell compartment.

Results

Here, we show that Notch4 expression is required for tumor onset and early tumor perfusion in a mouse model of breast cancer. We found that Notch4 expression is upregulated in mouse and human mammary tumor vasculature. Moreover, host Notch4 deficiency delayed the onset of MMTV-PyMT tumors, wild type for Notch4, after transplantation. Vessel perfusion was decreased in tumors established in Notch4-deficient hosts. Unlike in inhibition of Notch1 or Dll4, vessel density and branching in tumors developed in Notch4-deficient mice were unchanged. However, final tumor size was similar between tumors grown in wild type and Notch4 null hosts.

Conclusion

Our results suggest a novel role for Notch4 in the establishment of tumor colonies and vessel perfusion of transplanted mammary tumors.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fortini ME: Notch signaling: the core pathway and its posttranslational regulation. Dev Cell. 2009, 16 (5): 633-647. 10.1016/j.devcel.2009.03.010.CrossRefPubMed Fortini ME: Notch signaling: the core pathway and its posttranslational regulation. Dev Cell. 2009, 16 (5): 633-647. 10.1016/j.devcel.2009.03.010.CrossRefPubMed
2.
go back to reference Uyttendaele H, Marazzi G, Wu G, Yan Q, Sassoon D, Kitajewski J: Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development. 1996, 122 (7): 2251-2259.PubMed Uyttendaele H, Marazzi G, Wu G, Yan Q, Sassoon D, Kitajewski J: Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development. 1996, 122 (7): 2251-2259.PubMed
3.
go back to reference Krebs LT, Xue Y, Norton CR, Shutter JR, Maguire M, Sundberg JP, Gallahan D, Closson V, Kitajewski J, Callahan R: Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 2000, 14 (11): 1343-1352.PubMedCentralPubMed Krebs LT, Xue Y, Norton CR, Shutter JR, Maguire M, Sundberg JP, Gallahan D, Closson V, Kitajewski J, Callahan R: Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 2000, 14 (11): 1343-1352.PubMedCentralPubMed
4.
go back to reference Swiatek PJ, Lindsell CE, del Amo FF, Weinmaster G, Gridley T: Notch1 is essential for postimplantation development in mice. Genes Dev. 1994, 8 (6): 707-719. 10.1101/gad.8.6.707.CrossRefPubMed Swiatek PJ, Lindsell CE, del Amo FF, Weinmaster G, Gridley T: Notch1 is essential for postimplantation development in mice. Genes Dev. 1994, 8 (6): 707-719. 10.1101/gad.8.6.707.CrossRefPubMed
5.
go back to reference Takeshita K, Satoh M, Ii M, Silver M, Limbourg FP, Mukai Y, Rikitake Y, Radtke F, Gridley T, Losordo DW: Critical role of endothelial Notch1 signaling in postnatal angiogenesis. Circ Res. 2007, 100 (1): 70-78. 10.1161/01.RES.0000254788.47304.6e.PubMedCentralCrossRefPubMed Takeshita K, Satoh M, Ii M, Silver M, Limbourg FP, Mukai Y, Rikitake Y, Radtke F, Gridley T, Losordo DW: Critical role of endothelial Notch1 signaling in postnatal angiogenesis. Circ Res. 2007, 100 (1): 70-78. 10.1161/01.RES.0000254788.47304.6e.PubMedCentralCrossRefPubMed
6.
go back to reference Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971, 285 (21): 1182-1186. 10.1056/NEJM197111182852108.CrossRefPubMed Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971, 285 (21): 1182-1186. 10.1056/NEJM197111182852108.CrossRefPubMed
7.
go back to reference Kofler NM, Shawber CJ, Kangsamaksin T, Reed HO, Galatioto J, Kitajewski J: Notch signaling in developmental and tumor angiogenesis. Genes Cancer. 2011, 2 (12): 1106-1116. 10.1177/1947601911423030.PubMedCentralCrossRefPubMed Kofler NM, Shawber CJ, Kangsamaksin T, Reed HO, Galatioto J, Kitajewski J: Notch signaling in developmental and tumor angiogenesis. Genes Cancer. 2011, 2 (12): 1106-1116. 10.1177/1947601911423030.PubMedCentralCrossRefPubMed
8.
go back to reference Phng LK, Gerhardt H: Angiogenesis: a team effort coordinated by notch. Dev Cell. 2009, 16 (2): 196-208. 10.1016/j.devcel.2009.01.015.CrossRefPubMed Phng LK, Gerhardt H: Angiogenesis: a team effort coordinated by notch. Dev Cell. 2009, 16 (2): 196-208. 10.1016/j.devcel.2009.01.015.CrossRefPubMed
9.
go back to reference Noguera-Troise I, Daly C, Papadopoulos NJ, Coetzee S, Boland P, Gale NW, Lin HC, Yancopoulos GD, Thurston G: Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature. 2006, 444 (7122): 1032-1037. 10.1038/nature05355.CrossRefPubMed Noguera-Troise I, Daly C, Papadopoulos NJ, Coetzee S, Boland P, Gale NW, Lin HC, Yancopoulos GD, Thurston G: Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature. 2006, 444 (7122): 1032-1037. 10.1038/nature05355.CrossRefPubMed
10.
go back to reference Ridgway J, Zhang G, Wu Y, Stawicki S, Liang WC, Chanthery Y, Kowalski J, Watts RJ, Callahan C, Kasman I: Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature. 2006, 444 (7122): 1083-1087. 10.1038/nature05313.CrossRefPubMed Ridgway J, Zhang G, Wu Y, Stawicki S, Liang WC, Chanthery Y, Kowalski J, Watts RJ, Callahan C, Kasman I: Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature. 2006, 444 (7122): 1083-1087. 10.1038/nature05313.CrossRefPubMed
11.
go back to reference Wu Y, Cain-Hom C, Choy L, Hagenbeek TJ, de Leon GP, Chen Y, Finkle D, Venook R, Wu X, Ridgway J: Therapeutic antibody targeting of individual Notch receptors. Nature. 2010, 464 (7291): 1052-1057. 10.1038/nature08878.CrossRefPubMed Wu Y, Cain-Hom C, Choy L, Hagenbeek TJ, de Leon GP, Chen Y, Finkle D, Venook R, Wu X, Ridgway J: Therapeutic antibody targeting of individual Notch receptors. Nature. 2010, 464 (7291): 1052-1057. 10.1038/nature08878.CrossRefPubMed
12.
go back to reference Braren R, Hu H, Kim YH, Beggs HE, Reichardt LF, Wang R: Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. J Cell Biol. 2006, 172 (1): 151-162. 10.1083/jcb.200506184.PubMedCentralCrossRefPubMed Braren R, Hu H, Kim YH, Beggs HE, Reichardt LF, Wang R: Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. J Cell Biol. 2006, 172 (1): 151-162. 10.1083/jcb.200506184.PubMedCentralCrossRefPubMed
13.
go back to reference Murphy PA, Lu G, Shiah S, Bollen AW, Wang RA: Endothelial Notch signaling is upregulated in human brain arteriovenous malformations and a mouse model of the disease. Lab Invest. 2009, 89 (9): 971-982. 10.1038/labinvest.2009.62.PubMedCentralCrossRefPubMed Murphy PA, Lu G, Shiah S, Bollen AW, Wang RA: Endothelial Notch signaling is upregulated in human brain arteriovenous malformations and a mouse model of the disease. Lab Invest. 2009, 89 (9): 971-982. 10.1038/labinvest.2009.62.PubMedCentralCrossRefPubMed
14.
go back to reference Welm AL, Kim S, Welm BE, Bishop JM: MET and MYC cooperate in mammary tumorigenesis. Proc Natl Acad Sci USA. 2005, 102 (12): 4324-4329. 10.1073/pnas.0500470102.PubMedCentralCrossRefPubMed Welm AL, Kim S, Welm BE, Bishop JM: MET and MYC cooperate in mammary tumorigenesis. Proc Natl Acad Sci USA. 2005, 102 (12): 4324-4329. 10.1073/pnas.0500470102.PubMedCentralCrossRefPubMed
15.
16.
go back to reference Wang R, Ferrell LD, Faouzi S, Maher JJ, Bishop JM: Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. J Cell Biol. 2001, 153 (5): 1023-1034. 10.1083/jcb.153.5.1023.PubMedCentralCrossRefPubMed Wang R, Ferrell LD, Faouzi S, Maher JJ, Bishop JM: Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. J Cell Biol. 2001, 153 (5): 1023-1034. 10.1083/jcb.153.5.1023.PubMedCentralCrossRefPubMed
17.
go back to reference Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S: Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol. 2007, 8 (5): R76-10.1186/gb-2007-8-5-r76.PubMedCentralCrossRefPubMed Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S: Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol. 2007, 8 (5): R76-10.1186/gb-2007-8-5-r76.PubMedCentralCrossRefPubMed
18.
go back to reference Guy CT, Cardiff RD, Muller WJ: Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol. 1992, 12 (3): 954-961.PubMedCentralCrossRefPubMed Guy CT, Cardiff RD, Muller WJ: Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol. 1992, 12 (3): 954-961.PubMedCentralCrossRefPubMed
19.
go back to reference Djonov V, Andres AC, Ziemiecki A: Vascular remodelling during the normal and malignant life cycle of the mammary gland. Microsc Res Tech. 2001, 52 (2): 182-189. 10.1002/1097-0029(20010115)52:2<182::AID-JEMT1004>3.0.CO;2-M.CrossRefPubMed Djonov V, Andres AC, Ziemiecki A: Vascular remodelling during the normal and malignant life cycle of the mammary gland. Microsc Res Tech. 2001, 52 (2): 182-189. 10.1002/1097-0029(20010115)52:2<182::AID-JEMT1004>3.0.CO;2-M.CrossRefPubMed
20.
go back to reference Rossiter H, Barresi C, Ghannadan M, Gruber F, Mildner M, Fodinger D, Tschachler E: Inactivation of VEGF in mammary gland epithelium severely compromises mammary gland development and function. FASEB J. 2007, 21 (14): 3994-4004. 10.1096/fj.07-8720com.CrossRefPubMed Rossiter H, Barresi C, Ghannadan M, Gruber F, Mildner M, Fodinger D, Tschachler E: Inactivation of VEGF in mammary gland epithelium severely compromises mammary gland development and function. FASEB J. 2007, 21 (14): 3994-4004. 10.1096/fj.07-8720com.CrossRefPubMed
21.
go back to reference Singh N, Phillips RA, Iscove NN, Egan SE: Expression of notch receptors, notch ligands, and fringe genes in hematopoiesis. Exp Hematol. 2000, 28 (5): 527-534. 10.1016/S0301-472X(00)00146-6.CrossRefPubMed Singh N, Phillips RA, Iscove NN, Egan SE: Expression of notch receptors, notch ligands, and fringe genes in hematopoiesis. Exp Hematol. 2000, 28 (5): 527-534. 10.1016/S0301-472X(00)00146-6.CrossRefPubMed
22.
go back to reference Brem SS, Gullino PM, Medina D: Angiogenesis: a marker for neoplastic transformation of mammary papillary hyperplasia. Science. 1977, 195 (4281): 880-882. 10.1126/science.402692.CrossRefPubMed Brem SS, Gullino PM, Medina D: Angiogenesis: a marker for neoplastic transformation of mammary papillary hyperplasia. Science. 1977, 195 (4281): 880-882. 10.1126/science.402692.CrossRefPubMed
23.
go back to reference Leong KG, Karsan A: Recent insights into the role of Notch signaling in tumorigenesis. Blood. 2006, 107 (6): 2223-2233. 10.1182/blood-2005-08-3329.CrossRefPubMed Leong KG, Karsan A: Recent insights into the role of Notch signaling in tumorigenesis. Blood. 2006, 107 (6): 2223-2233. 10.1182/blood-2005-08-3329.CrossRefPubMed
24.
go back to reference Ranganathan P, Weaver KL, Capobianco AJ: Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer. 2011, 11 (5): 338-351. 10.1038/nrc3035.CrossRefPubMed Ranganathan P, Weaver KL, Capobianco AJ: Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer. 2011, 11 (5): 338-351. 10.1038/nrc3035.CrossRefPubMed
25.
go back to reference Harrison H, Farnie G, Howell SJ, Rock RE, Stylianou S, Brennan KR, Bundred NJ, Clarke RB: Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res. 2010, 70 (2): 709-718. 10.1158/0008-5472.CAN-09-1681.PubMedCentralCrossRefPubMed Harrison H, Farnie G, Howell SJ, Rock RE, Stylianou S, Brennan KR, Bundred NJ, Clarke RB: Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res. 2010, 70 (2): 709-718. 10.1158/0008-5472.CAN-09-1681.PubMedCentralCrossRefPubMed
26.
go back to reference Mittal S, Subramanyam D, Dey D, Kumar RV, Rangarajan A: Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis. Mol Cancer. 2009, 8: 128-10.1186/1476-4598-8-128.PubMedCentralCrossRefPubMed Mittal S, Subramanyam D, Dey D, Kumar RV, Rangarajan A: Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis. Mol Cancer. 2009, 8: 128-10.1186/1476-4598-8-128.PubMedCentralCrossRefPubMed
27.
go back to reference Speiser J, Foreman K, Drinka E, Godellas C, Perez C, Salhadar A, Ersahin C, Rajan P: Notch-1 and Notch-4 biomarker expression in triple-negative breast cancer. Int J Surg Pathol. 2012, 20 (2): 139-145.CrossRefPubMed Speiser J, Foreman K, Drinka E, Godellas C, Perez C, Salhadar A, Ersahin C, Rajan P: Notch-1 and Notch-4 biomarker expression in triple-negative breast cancer. Int J Surg Pathol. 2012, 20 (2): 139-145.CrossRefPubMed
28.
go back to reference Sun Y, Lowther W, Kato K, Bianco C, Kenney N, Strizzi L, Raafat D, Hirota M, Khan NI, Bargo S: Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta signaling. Oncogene. 2005, 24 (34): 5365-5374. 10.1038/sj.onc.1208528.CrossRefPubMed Sun Y, Lowther W, Kato K, Bianco C, Kenney N, Strizzi L, Raafat D, Hirota M, Khan NI, Bargo S: Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta signaling. Oncogene. 2005, 24 (34): 5365-5374. 10.1038/sj.onc.1208528.CrossRefPubMed
29.
go back to reference Jubb AM, Soilleux EJ, Turley H, Steers G, Parker A, Low I, Blades J, Li JL, Allen P, Leek R: Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancer. Am J Pathol. 2010, 176 (4): 2019-2028. 10.2353/ajpath.2010.090908.PubMedCentralCrossRefPubMed Jubb AM, Soilleux EJ, Turley H, Steers G, Parker A, Low I, Blades J, Li JL, Allen P, Leek R: Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancer. Am J Pathol. 2010, 176 (4): 2019-2028. 10.2353/ajpath.2010.090908.PubMedCentralCrossRefPubMed
30.
go back to reference Potente M, Gerhardt H, Carmeliet P: Basic and therapeutic aspects of angiogenesis. Cell. 2011, 146 (6): 873-887. 10.1016/j.cell.2011.08.039.CrossRefPubMed Potente M, Gerhardt H, Carmeliet P: Basic and therapeutic aspects of angiogenesis. Cell. 2011, 146 (6): 873-887. 10.1016/j.cell.2011.08.039.CrossRefPubMed
31.
go back to reference Scehnet JS, Jiang W, Kumar SR, Krasnoperov V, Trindade A, Benedito R, Djokovic D, Borges C, Ley EJ, Duarte A: Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood. 2007, 109 (11): 4753-4760. 10.1182/blood-2006-12-063933.PubMedCentralCrossRefPubMed Scehnet JS, Jiang W, Kumar SR, Krasnoperov V, Trindade A, Benedito R, Djokovic D, Borges C, Ley EJ, Duarte A: Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood. 2007, 109 (11): 4753-4760. 10.1182/blood-2006-12-063933.PubMedCentralCrossRefPubMed
32.
go back to reference Hanahan D, Coussens LM: Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012, 21 (3): 309-322. 10.1016/j.ccr.2012.02.022.CrossRefPubMed Hanahan D, Coussens LM: Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012, 21 (3): 309-322. 10.1016/j.ccr.2012.02.022.CrossRefPubMed
Metadata
Title
Notch4 is required for tumor onset and perfusion
Authors
Maria José Costa
Xiaoqing Wu
Henar Cuervo
Ruchika Srinivasan
Seth K Bechis
Ellen Cheang
Olivera Marjanovic
Thomas Gridley
Christin A Cvetic
Rong A Wang
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Vascular Cell / Issue 1/2013
Electronic ISSN: 2045-824X
DOI
https://doi.org/10.1186/2045-824X-5-7

Other articles of this Issue 1/2013

Vascular Cell 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.